Skip to main content
. 2020 Jul 27;12:6363–6371. doi: 10.2147/CMAR.S260857

Table 4.

Logistic Regression Analyses for Variables Associated with Elevated PASP

Unadjusted Adjusteda
HR (95% CI) p value HR (95% CI) p value
Age 1.065 (1.039–1.090) <0.001 1.060 (1.034–1.087) < 0.001
Sex 0.812 (0.535–1.233) 0.329
BMI 0.969 (0.914–1.027) 0.291
Symptom 1.271 (0.839–1.926) 0.258
Alcohol history 1.075 (0.646–1.789) 0.781
Smoking history 1.457 (0.976–2.177) 0.066
GGO (yes) 1.033 (0.597–1.787) 0.907
CCI (>2) 1.195 (0.765–1.867) 0.434
Coagulopathyb 3.867 (2.468–6.057) <0.001 3.380 (2.053–5.566) < 0.001
Intrapulmonary metastasis (yes) 3.625 (1.913–6.866) <0.001 3.329 (1.556–7.125) 0.002
Lymph node metastasis (yes) 1.425 (0.954–2.129) 0.084
Distant metastasis (yes) 1.757 (1.068–2.890) 0.027 0.857 (0.455–1.614) 0.633
Histological type 0.148
 Adenocarcinoma 3.697 (0.863–15.833) 0.078
 Squamous-cell carcinoma 3.806 (0.873–16.598) 0.075
Clinical stagec 1.492 (0.990–2.250) 0.056

Notes: aMultivariate model included all variables that were associated with elevated PASP at univariate analyses. bCoagulopathy (dichotomous). cClinical stage (dichotomous).